Benzinga | Aug 16, 2021 11:26AM EDT

Altimmune Sponsored Study ALT-801 In Diabetic And Non-Diabetic Overweight And Obese Subjects With Non-alcoholic Fatty Liver Disease Posted To clinical Trials Website Not Yet Recruiting

https://benzinga.slack.com/archives/G30T1LFMW/p1629127523156600